Pyrido pyrimidinones as selective agonists of the high affinity niacin receptor GPR109A: optimization of in vitro activity.

J. Peters,Holger Kühne,H. Dehmlow,U. Grether,A. Conte,D. Hainzl,C. Hertel,N. Kratochwil,Michael B. Otteneder,R. Narquizian,Constantinos G. Panousis,F. Ricklin,S. Röver
DOI: https://doi.org/10.1016/j.bmcl.2010.07.108
IF: 2.94
2010-09-15
Bioorganic & Medicinal Chemistry Letters
Abstract:
What problem does this paper attempt to address?